CRO

Explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development. Gain insights to reduce attrition rates and optimise development programmes through eff ective assay development. Learn about the latest multiplexed tools impacting biomarker research and validation, from multi-omic cytometry through to mass spectrometry & immunoassays.

Connecting global pharma, biotech and academia for high-level discussions on the latest innovations in biologics development. Consisting of the Proteins & Antibodies Congress, Bispecifics in Discovery & Development Congress and Peptides & Oligonucleotides Congress, visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the biologics industry in the future.

This one day event, the day before DPHARM, is centered on connecting the value chain of patient data
(from early drug research to commercialization) with digital technology.

This conference formerly called “Mobile in Clinical Trials” focused on assessing, employing and scaling
mobile tech to help more patients participate and be able to collect patient data remotely.

The conference is expanding to assess all sources of patient data including patient experience data, and how
to best connect the data to optimize clinical trials for all stakeholders.

This conference will include a variety of technological solutions and consider how patient data could be
better utilized in clinical trials.

A gathering of 220+ of the leading innovators, investors and executives from around the nation discussing the timeliest issues and opportunities. 

In a market that is constantly adapting and adjusting to the needs of the healthcare field, real-world evidence (RWE) is increasingly becoming important for regulatory and reimbursement decision-making. RWE, in relation to the real-world data that is collected in combination with the advancement of artificial intelligence-based analytics platforms, has led to the realtime analysis of data to better understand and gain insights on disease, approaches to treatment, and how to substantiate coverage decisions.

Summit for Clinical Trials Operations Executives Europe is a two-day event serving clin ops execs, functional heads, category managers and those responsible for the planning and management of clinical trials. Leaders from large and small pharma,
specialty pharma, biotech, and academic research come together to share best practices and discuss the new era of analytics-driven, patient-centric trials.

The SCOPE Summit offers three stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Resource Management and Capacity Planning, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Supply Chain, and Precision Medicine.

Our established genomics event will be returning to London this autumn featuring the 15th Annual Next Generation Sequencing & Clinical Diagnostics, 10th Annual Single Cell Analysis, 8th Annual Genome Editing and 4th Annual Digital PCR Congresses. From clinical genomics updates and single cell analysis current & emerging tools, through to genome editing techniques for assessing specificity for on and off targets and applications of digital PCR in oncology, this is the event to attend this fall to stay at the forefront of genomics research.

Featuring focused discussions, presentations, and networking on multi-omic data integration, single cell & spatial analysis, genome editing in drug discovery & development and novel genome editing technologies.

An intensive 2-day in person meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development. From new and exciting to the latest in products & services, this event will bring together over 150 leading companies for in-depth discussions, knowledge sharing and focused networking. Colocated with the RNA Therapeutics & Delivery Europe: In Person.